Skip to main content
Log in

A Prospective Analysis of the Effect of Blue-Dye Volume on Sentinel Lymph Node Mapping Success and Incidence of Allergic Reaction in Patients With Breast Cancer

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

This study examined whether the volume of isosulfan blue dye used in sentinel lymph node (SLN) mapping in breast cancer is related to the SLN identification rate or to the incidence of allergic reactions.

Methods

From January 2001 to November 2002, 1728 breast cancer patients underwent 1832 SLN mapping procedures with the combined technique of intraparenchymal blue dye and intradermal radioisotope. Details of each procedure and all allergic reactions were prospectively recorded. Bilateral synchronous SLN procedures were considered as one dye exposure but as two distinct procedures for determining mapping success. Dye-only success was defined as the proportion of cases in which the SLN was identified by blue dye alone. Overall dye success was defined as the proportion of cases in which the SLN was identified by blue dye with or without isotope.

Results

When stratified by volume of blue dye, there were no significant differences in dye-only successes, overall dye successes, or mapping failures. Allergic reactions were documented in 31 (1.8%) of 1728 patients. Hypotensive reactions occurred in 3 (.2%) of 1728 patients; 2 (.1%) required pressor support. There was a nonsignificant trend toward fewer allergic reactions with smaller volumes of blue dye.

Conclusions

In combined-technique SLN mapping protocols for breast cancer, using smaller volumes of blue dye may represent a means of optimizing the safety of the procedure without compromising its success.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Hill ADK, Tran KN, Akhurst T, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999;229:528–35.

    Google Scholar 

  2. Cody HS, Fey J, Akhurst T, et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 2001;8:13–9.

    Google Scholar 

  3. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560–6.

    Google Scholar 

  4. Cody HS, Borgen PI. State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center. Surg Oncol 1999;8:85–91.

    Article  PubMed  Google Scholar 

  5. Kuerer HM, Hunt KK, Singletary E, Ames FC. Blue hives during lymphatic mapping for breast cancer (letter). J Clin Oncol 2001;19:2573–4.

    Google Scholar 

  6. Lymphazurin 1% (package insert). Bedford, OH: Ben Venue Lab-oratories Inc, 1997.

  7. Kuerer HM, Wayne JD, Ross MI. Anaphylaxis during breast cancer lymphatic mapping (letter). Surgery 2001;129:119–20.

    Google Scholar 

  8. Lyew MA, Gamblin TC, Ayoub M. Systemic anaphylaxis associated with intramammary isosulfan blue injection used for sentinel node detection under general anesthesia. Anesthesiology 2000;93:1145–6.

    Google Scholar 

  9. Leong SP, Donegan E, Heffernon W, et al. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol 2000;7:361–6.

    Google Scholar 

  10. Efron P, Knudsen E, Hirshorn S, Copeland EM. Anaphylactic reaction to isosulfan blue used for sentinel node biopsy: case report and literature review. Breast J 2002;8:396–9.

    Google Scholar 

  11. Albo D, Wayne JD, Hunt KK, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 2001;182:393–8.

    Google Scholar 

  12. Montgomery LL, Thorne AC, Van Zee KJ, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 2002;95:385–8.

    Google Scholar 

  13. Linehan DC, Hill ADK, Tran KN, et al. Sentinel lymph node localization in breast cancer: unfiltered isotope is superior to filtered. J Am Coll Surg 1999;188:377–81.

    Google Scholar 

  14. McCarter MD, Yeung H, Yeh S, et al. Localization of the sentinel node in breast cancer: identical results with same-day and day-before isotope injection. Ann Surg Oncol 2001;8:682–6.

    Google Scholar 

  15. Boolbol SK, Fey JV, Borgen PI, et al. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma. Ann Surg Oncol 2001;8:20–4.

    Google Scholar 

  16. McMasters KM, Wong SL, Martin RCG, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 2001;233:676–87.

    Article  CAS  PubMed  Google Scholar 

  17. Bares R, Muller B, Fass J, Buell U, Schumpelick V. The radiation dose to surgical personnel during intraoperative radioimmunoscintimetry. Eur J Nucl Med 1992;19:110–2.

    Google Scholar 

  18. Miner TJ, Shriver CD, Flicek PR, et al. Guidelines for the safe use of radioactive materials during localization and resection of the sentinel lymph node. Ann Surg Oncol 1999;6:75–82.

    Google Scholar 

  19. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65–70.

    MathSciNet  MATH  Google Scholar 

  20. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391–401.

    PubMed  Google Scholar 

  21. Derossis AM, Fey J, Yeung H, et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 2001;193:473–8.

    Google Scholar 

  22. Vokach-Brodsky L, Jeffrey SS, Lemmens HJM, Brock-Utne JG. Isosulfan blue affects pulse oximetry. Anesthesiology 2000;93:1002–3.

    Google Scholar 

  23. Kelloher JF. Pulse oximetry. J Clin Monit 1989;5:37–40.

    Google Scholar 

  24. Wayne JD, Albo D, Hunt K, et al. Anaphylactic reaction to isosulfan blue dye (IBD) during sentinel lymph node biopsy (SLNB) is more common in breast cancer than in melanoma (abstract 150). Proc ASCO 2001;20:38a.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tari A. King MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

King, T.A., Fey, J.V., Van Zee, K.J. et al. A Prospective Analysis of the Effect of Blue-Dye Volume on Sentinel Lymph Node Mapping Success and Incidence of Allergic Reaction in Patients With Breast Cancer. Ann Surg Oncol 11, 535–541 (2004). https://doi.org/10.1245/ASO.2004.10.014

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2004.10.014

Key Words

Navigation